| P50 | author | Bernard Moss | Q822617 |
| P2093 | author name string | P S Satheshkumar | |
| | Patrick Sanz | |
| | Luis C Anton | |
| P2860 | cites work | Inhibition of HeLa Cell Protein Synthesis by the Vaccinia Virion | Q37124144 |
| | Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety | Q37249251 |
| | Ubiquitin is part of the retrovirus budding machinery | Q37281238 |
| | The ubiquitin-proteasome system facilitates the transfer of murine coronavirus from endosome to cytoplasm during virus entry | Q37746712 |
| | Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice | Q39976598 |
| | Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. | Q40073550 |
| | Reduction of infectious bursal disease virus replication in cultured cells by proteasome inhibitors | Q40097756 |
| | Antiviral activity of proteasome inhibitors in herpes simplex virus-1 infection: role of nuclear factor-kappaB. | Q40170810 |
| | Protein synthesis upon acute nutrient restriction relies on proteasome function | Q40336957 |
| | The poxvirus p28 virulence factor is an E3 ubiquitin ligase | Q40501664 |
| | The ubiquitin-proteasome machinery is essential for nuclear translocation of incoming minute virus of mice | Q40543452 |
| | The Ubiquitin‐Vacuolar Protein Sorting System is Selectively Required During Entry of Influenza Virus into Host Cells | Q40616491 |
| | Adenovirus E4-34kDa requires active proteasomes to promote late gene expression | Q40621055 |
| | Intracellular and extracellular vaccinia virions enter cells by different mechanisms | Q41046992 |
| | Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes | Q42792322 |
| | Proteasome inhibitors reduce luciferase and beta-galactosidase activity in tissue culture cells | Q43963594 |
| | F-box-like domains are present in most poxvirus ankyrin repeat proteins | Q43986616 |
| | Viruses and the 26S proteasome: hacking into destruction | Q44310046 |
| | THE INTRACELLULAR UNCOATING OF POXVIRUS DNA. I. THE FATE OF RADIOACTIVELY-LABELED RABBITPOX VIRUS. | Q45715081 |
| | A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies | Q45787555 |
| | Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus. | Q46777402 |
| | Inhibition of the extracellular signal-regulated kinase signaling pathway is correlated with proteasome inhibitor suppression of coxsackievirus replication. | Q53552369 |
| | Biogenesis of vaccinia: Separation of early stages from maturation by means of hydroxyurea | Q71756827 |
| | Selection of recombinant vaccinia viruses on the basis of plaque formation | Q71866680 |
| | Induction of cytoplasmic ribonucleic acid (RNA) synthesis in vaccinia-infected LM cells during inhibition of protein synthesis | Q72878795 |
| | Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response | Q73940178 |
| | THE INTRACELLULAR UNCOATING OF POXVIRUS DNA. II. THE MOLECULAR BASIS OF THE UNCOATING PROCESS | Q76742709 |
| | Structural mechanisms underlying posttranslational modification by ubiquitin-like proteins | Q80262122 |
| | Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity | Q24679238 |
| | Origin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and requires all five known poxvirus replication factors | Q24796835 |
| | Modification of proteins by ubiquitin and ubiquitin-like proteins | Q28244250 |
| | Poxviral B1 kinase overcomes barrier to autointegration factor, a host defense against virus replication | Q28910319 |
| | Proteasome inhibitors: valuable new tools for cell biologists | Q29620573 |
| | Ubiquitin and ubiquitin-like proteins as multifunctional signals | Q30014838 |
| | Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction | Q31016943 |
| | Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans | Q33271767 |
| | The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex | Q33324557 |
| | Different effect of proteasome inhibition on vesicular stomatitis virus and poliovirus replication | Q33326624 |
| | Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes | Q33843207 |
| | The PHD/LAP-domain protein M153R of myxomavirus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4 | Q34464231 |
| | An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells | Q34576212 |
| | Sequence-nonspecific replication of transfected plasmid DNA in poxvirus-infected cells | Q35588066 |
| | Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability | Q35916071 |
| | Messenger RNA synthesis by a "coated" viral genome | Q35968463 |
| | Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells | Q36098835 |
| | Poxvirus entry and membrane fusion | Q36346787 |
| | Bortezomib: proteasome inhibition as an effective anticancer therapy | Q36366801 |
| | Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step | Q36498260 |
| | The ubiquitin-proteasome pathway in viral infections | Q36538328 |
| | Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes | Q36648508 |
| | Proteasome inhibitors: antitumor effects and beyond | Q36649676 |
| | Ectromelia virus BTB/kelch proteins, EVM150 and EVM167, interact with cullin-3-based ubiquitin ligases | Q36740202 |
| | Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene | Q36765625 |
| | General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. | Q36913229 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Vaccinia virus | Q1986297 |
| | ubiquitin-proteasome system | Q47175589 |
| P304 | page(s) | 2469-2479 | |
| P577 | publication date | 2009-01-07 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes | |
| P478 | volume | 83 | |